Guardant Health
GH
#1019
Rank
$23.48 B
Marketcap
$175.00
Share price
2.50%
Change (1 day)
76.91%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report